Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors ...Middle East

A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors )

Also on site :

• Bianca Censori Wears Edible Lingerie in Public With Kanye West
• Country Hitmaker Brings Out Unexpected Guest in 'Dream Collab' Moment
• Starmer will slash firms’ energy bills amid warnings net zero costs are crippling British industry